These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35314626)

  • 1. Ipsilateral Recurrence of DCIS in Relation to Radiomics Features on Contrast Enhanced Breast MRI.
    Park GE; Kim SH; Lee EB; Nam Y; Sung W
    Tomography; 2022 Mar; 8(2):596-606. PubMed ID: 35314626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility analysis of magnetic resonance imaging-based radiomics features for preoperative prediction of nuclear grading of ductal carcinoma in situ.
    Zhao MR; Ma WJ; Song XC; Li ZJ; Shao ZZ; Lu H; Zhao R; Guo YJ; Ye ZX; Liu PF
    Gland Surg; 2023 Sep; 12(9):1209-1223. PubMed ID: 37842532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrafast MRI and T1 and T2 Radiomics for Predicting Invasive Components in Ductal Carcinoma in Situ Diagnosed With Percutaneous Needle Biopsy.
    Kim MY; Yoen H; Ji H; Park SJ; Kim SM; Han W; Cho N
    Korean J Radiol; 2023 Dec; 24(12):1190-1199. PubMed ID: 38016679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ductal Carcinoma in Situ: Quantitative Preoperative Breast MR Imaging Features Associated with Recurrence after Treatment.
    Luo J; Johnston BS; Kitsch AE; Hippe DS; Korde LA; Javid S; Lee JM; Peacock S; Lehman CD; Partridge SC; Rahbar H
    Radiology; 2017 Dec; 285(3):788-797. PubMed ID: 28914599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminating low-grade ductal carcinoma in situ (DCIS) from non-low-grade DCIS or DCIS upgraded to invasive carcinoma: effective texture features on ultrafast dynamic contrast-enhanced magnetic resonance imaging.
    Mori N; Abe H; Mugikura S; Miyashita M; Mori Y; Oguma Y; Hirasawa M; Sato S; Takase K
    Breast Cancer; 2021 Sep; 28(5):1141-1153. PubMed ID: 33900583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of MRI-derived radiomic biomarker with disease-free survival in patients with early-stage cervical cancer.
    Fang J; Zhang B; Wang S; Jin Y; Wang F; Ding Y; Chen Q; Chen L; Li Y; Li M; Chen Z; Liu L; Liu Z; Tian J; Zhang S
    Theranostics; 2020; 10(5):2284-2292. PubMed ID: 32089742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of the histologic upgrade of ductal carcinoma
    Lee HJ; Park JH; Nguyen AT; Do LN; Park MH; Lee JS; Park I; Lim HS
    Front Oncol; 2022; 12():1032809. PubMed ID: 36408141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiomics signature on 3T dynamic contrast-enhanced magnetic resonance imaging for estrogen receptor-positive invasive breast cancers: Preliminary results for correlation with Oncotype DX recurrence scores.
    Nam KJ; Park H; Ko ES; Lim Y; Cho HH; Lee JE
    Medicine (Baltimore); 2019 Jun; 98(23):e15871. PubMed ID: 31169691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clinical radiomics nomogram preoperatively to predict ductal carcinoma in situ with microinvasion in women with biopsy-confirmed ductal carcinoma in situ: a preliminary study.
    Huang Z; Chen X; Jiang N; Hu S; Hu C
    BMC Med Imaging; 2023 Sep; 23(1):118. PubMed ID: 37679713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Background parenchymal signal enhancement ratio at preoperative MR imaging: association with subsequent local recurrence in patients with ductal carcinoma in situ after breast conservation surgery.
    Kim SA; Cho N; Ryu EB; Seo M; Bae MS; Chang JM; Moon WK
    Radiology; 2014 Mar; 270(3):699-707. PubMed ID: 24126372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative Prediction of Lymph Node Metastasis of Pancreatic Ductal Adenocarcinoma Based on a Radiomics Nomogram of Dual-Parametric MRI Imaging.
    Shi L; Wang L; Wu C; Wei Y; Zhang Y; Chen J
    Front Oncol; 2022; 12():927077. PubMed ID: 35875061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive Performance of Radiomic Features Extracted from Breast MR Imaging in Postoperative Upgrading of Ductal Carcinoma in Situ to Invasive Carcinoma.
    Satake H; Kinoshita F; Ishigaki S; Kato K; Jo Y; Shimada S; Masuda N; Naganawa S
    Magn Reson Med Sci; 2024 May; ():. PubMed ID: 38749758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk stratification of ductal carcinoma in situ using whole-lesion histogram analysis of the apparent diffusion coefficient.
    Kim JY; Kim JJ; Lee JW; Lee NK; Lee G; Kang T; Park H; Son YH; Grimm R
    Eur Radiol; 2019 Feb; 29(2):485-493. PubMed ID: 30073498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction Model For Extensive Ductal Carcinoma In Situ Around Early-Stage Invasive Breast Cancer.
    Knuttel FM; van der Velden BH; Loo CE; Elias SG; Wesseling J; van den Bosch MA; Gilhuijs KG
    Invest Radiol; 2016 Jul; 51(7):462-8. PubMed ID: 26863579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting underestimation of ductal carcinoma in situ: a comparison between radiomics and conventional approaches.
    Li J; Song Y; Xu S; Wang J; Huang H; Ma W; Jiang X; Wu Y; Cai H; Li L
    Int J Comput Assist Radiol Surg; 2019 Apr; 14(4):709-721. PubMed ID: 30569330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiomic analysis of Gd-EOB-DTPA-enhanced MRI predicts Ki-67 expression in hepatocellular carcinoma.
    Fan Y; Yu Y; Wang X; Hu M; Hu C
    BMC Med Imaging; 2021 Jun; 21(1):100. PubMed ID: 34130644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes and imaging features of microinvasive carcinoma and ductal carcinoma in situ: Matched cohort study.
    Yoon GY; Choi WJ; Kim HH; Cha JH; Shin HJ; Chae EY
    Clin Imaging; 2023 Apr; 96():64-70. PubMed ID: 36827842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiparametric MRI-based radiomics nomogram for preoperative prediction of lymphovascular invasion and clinical outcomes in patients with breast invasive ductal carcinoma.
    Zhang J; Wang G; Ren J; Yang Z; Li D; Cui Y; Yang X
    Eur Radiol; 2022 Jun; 32(6):4079-4089. PubMed ID: 35050415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Values of Minimal Apparent Diffusion Coefficient,Difference between Ratios of Apparent Diffusion Coefficients,and Dynamic Contrast-enhanced Magnetic Resonance Imaging Features in Diagnosing Breast Ductal Carcinoma In Situ with Microinvasion].
    Wu P; Cui L; Guo BH; Wang YC; Cui JS
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Dec; 41(6):737-745. PubMed ID: 31907122
    [No Abstract]   [Full Text] [Related]  

  • 20. MRI-Based Radiomic Signature as a Prognostic Biomarker for HER2-Positive Invasive Breast Cancer Treated with NAC.
    Li Q; Xiao Q; Li J; Duan S; Wang H; Gu Y
    Cancer Manag Res; 2020; 12():10603-10613. PubMed ID: 33149669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.